SCHEMBL6683909

SCHEMBL6683909

Brc1cc[c]c(-c2cccc(Br)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
RAB9A P51151 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAOB P27338 4/20 0.41
HPGD P15428 2/20 0.41
MAPT P10636 2/20 0.41
HK1 P19367 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
MAOA P21397 1/20 0.41
NPC1 O15118 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
IDO1 P14902 1/20 0.38
METAP2 P50579 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 2/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8210753 0.85 ALDH1A1 (0.41) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL9649780 0.85 GABRP (0.42) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL28157175 0.85 ALDH1A1 (0.44) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL8506859 0.85 GABRP (0.42) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL11074877 0.82 ALDH1A1 (0.48) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL27825751 0.82 MAOB (0.43) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL7101700 0.81 MAOB (0.42) MEN1KMT2ARAB9AMAOBHPGD
SCHEMBL27947263 0.80 MAOB (0.42) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL7222379 0.80 RAB9A (0.44) MEN1KMT2ARAB9AALDH1A1MAOB
SCHEMBL15066583 0.79 CYP2A6 (0.32) ALDH1A1ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016049677-A1 METHOD OF TREATING CANCER THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2016-04-07 WO disclosed
WO-2004065350-A1 TERTIARY AMINO ACIDS, THEIR PRODUCTION AND USE MEDIGENE AKTIENGESELLSCHAFT (DE) 2004-08-05 WO disclosed
EP-0525573-A1 Organogermanium and organosilicon compounds, process for the preparation of the same and use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1993-02-03 EP disclosed